Silo Pharma Announced An Update On Its Dosage And Time-Release Ketamine-Loaded Implant, Designated As SP-26, Which Is Being Developed As A Potential At-Home Pain Relief Treatment For Fibromyalgia And Other Chronic Pain Conditions

SILO Pharma Inc Ordinary Shares +2.11% Pre

SILO Pharma Inc Ordinary Shares

SILO

1.94

1.94

+2.11%

0.00% Pre

Silo dosage and time-release formulation aim for potential first at-home Ketamine therapeutic

In collaboration with Sever Pharma Solutions, Silo's contract development and manufacturing partner, SP-26 is advancing through analytical testing and small batch pre-clinical proof of concept extrusion trials to determine drug release and stability.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via